We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Horizon Enters Licensing Agreement with LakePharma

News   Sep 17, 2015

 
Horizon Enters Licensing Agreement with LakePharma
 
 
 

RELATED ARTICLES

HIV Suppressed for up to Four Months by Novel Antibody

News

Regular infusions of an antibody that blocks the HIV binding site on human immune cells may have suppressed levels of HIV for up to four months.

READ MORE

Arsenic Harnessed to Create Broad-Spectrum Antibiotic

News

Although it contains arsenic, researchers say they tested the antibiotic's toxicity on human blood cells and reported that “it doesn’t kill human cells in tissue culture.”

READ MORE

A New Way to Build Novel Synthetic Biomolecules

News

Army scientists have discovered how to build novel synthetic biomolecule complexes that they believe are a critical step towards biotemplated advanced materials.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE